74
Participants
Start Date
September 30, 2009
Primary Completion Date
May 31, 2011
Study Completion Date
May 31, 2011
Afamelanotide
One 16mg subcutaneous implant every 2 months for 9 months.
Placebo
One 16mg subcutaneous implant every 2 months for 9 months.
Beaumont Hospital, Department of Dermatology, Dublin
Department of Dermatology , Heinrich-Heine-University Duesseldorf, Düsseldorf
Centre Français des Porphyries, Hôpital Louis Mourier, Colombes
HUS:n Iho-ja allergiasairaala (Skin and Allergy Hospital), Helsinki
Academisch Ziekenhuis Maastricht, Maastricht
Erasmus Medical Center, Rotterdam
St Woolos Hospital, Newport
Photobiology Unit - Hope Hospital, University of Manchester, Manchester
Lead Sponsor
Clinuvel Pharmaceuticals Limited
INDUSTRY